Mandibular fractures, resulting from either trauma or reconstructive surger
y, can be challenging craniofacial problems. The morbidity of failed fractu
re healing is significant and may require bone grafting. Donor site morbidi
ty and finite amounts of autogenous bone are major drawbacks of autogenous
bone grafting. Similarly, the use of allografts and xenografts may be assoc
iated with an increased risk of rejection, infection, and nonunion. To circ
umvent the limitations of bone grafting, research efforts have focused on f
ormulating a suitable bone substitute. The purpose of our study was to eval
uate the efficacy of type I collagen implants in repairing critical sized m
andibular defects in rats. Twelve male Sprague-Dawley rats (200-300g) were
divided equally into control and experimental groups. Full thickness, round
, four millimeter in diameter defects were created in the ramus of the righ
t mandible of all rats using an electrical burr at low speed. The defects w
ere irrigated of all bone chips, and either filled with a precisely fitted
disk of allogenic collagen type I gel (experimental animals) or left empty
(control animals). Animals were killed 6 weeks after surgery and healing of
the bone defects was assessed in a blinded fashion using radiologic and hi
stologic analysis. Radiologic analysis of the control group revealed a clea
r circular right mandibular defect in all animals, whereas the collagen dis
k implant group revealed an indistinct to nonexistent right mandibular defe
ct in all animals. Densitometric analysis revealed a significant difference
between these groups (*P = 0.01). Similarly, gross analysis of control man
dibles revealed a 4mm round, soft-tissue filled defect, while implanted def
ects demonstrated gross bone spanning the defect. Finally, histologic analy
sis of all control mandibles revealed clearly demarcated bony edges at the
defect border with connective tissue spanning the defect. In contrast, hist
ological analysis of all implanted mandibles revealed indistinct bony edges
at the defect border with a thin layer of osteoblasts and viable bone span
ning the defects. We have demonstrated the ability of type I collagen to pr
omote healing of a membranous bony defect that would not otherwise heal at
6 weeks. The suitability of type I collagen as a carrier matrix provides am
ple opportunity for tissue-engineered approaches to further facilitate bony
defect healing. Promoting bone formation through tissue engineering matric
es offers great promise for skeletal healing and reconstruction.